Real-World Evidence Companies: The 2026 RWE Vendor Landscape

RWE Vendor Landscape

Real-World Evidence Companies: The 2026 Vendor Landscape

14 to 15 October 2026Hampton Inn by Hilton, Boston Seaport, USA

Real-world evidence companies supply the data, analytics and services pharma and biotech use to prove value outside the clinical trial.

The leaders in this market meet their buyers in one place: RWE Connect 2026 in Boston.

Put Your Company in Front of 150+ RWE Buyers
Request the sponsorship prospectus. We reply within one business day.

    No public pricing. Enquiry-led, no obligation.

    150+Attendees
    60%Director / VP and Above
    40+Speakers
    200+Meetings Facilitated

    The market

    What Real-World Evidence Companies Do

    Real-world evidence draws on data generated outside the controlled trial, from electronic health records, claims, registries, wearables and routine care. A growing market of companies turns that data into evidence regulators, payers and commercial teams can act on. The landscape spans six broad categories.

    Real-World Data and Analytics Platforms
    EHR, claims and registry data linked and made analysis-ready at scale.
    AI and Machine Learning Providers
    Predictive models and advanced analytics applied to real-world data.
    CROs and Research Organisations
    Study design and execution for observational and comparative research.
    HEOR and Market Access Consultancies
    Value demonstration, payer evidence and HTA strategy.
    Digital Health and Patient-Centric Platforms
    Decentralised data capture, wearables and patient engagement.
    Regulatory and Compliance Technology
    Tokenization, data governance and submission support.

    Leading companies at RWE Connect 2026

    Companies Already on Board

    These companies have confirmed their place in front of the room.

    Platinum Sponsor

    Truveta

    Gold Sponsor

    Magnolia

    Silver Sponsor

    Forian

    Thought Leadership

    Arcadia

    Why companies sponsor

    Reach the Buyers, Not a Generalist Crowd

    Every attendee works with real-world data. For a company selling into this market, that is the difference between a booth and a pipeline.

    150+ Targeted BuyersRWE, HEOR, market access and data science professionals, 60% Director level and above.
    Pre-Scheduled 1:1 MeetingsName the buyers you want. The Partnering Lounge books the meetings before the doors open.
    Demos and Speaking SlotsShow your platform and shape the agenda in front of the people who buy it.

    Who is in the room

    Attendee Breakdown

    A senior, focused audience. Every attendee works with real-world data.

    60%Director / VP and Above
    Director / VP and AboveOther senior roles
    RWE & Real-World Data26%
    HEOR & Market Access24%
    Data Science & AI18%
    Clinical & Medical Affairs16%
    Regulatory, Payer & Policy10%
    Research, Academia & Startups6%

    Seniority is confirmed: 150+ attendees, around 60% at Director or VP level and above. The functional mix shown is indicative of the RWE Connect audience; confirmed registration splits are shared with sponsors from the live delegate list.

    The market

    A Fast-Growing Field, in the City Built for It

    Real-world evidence is one of the fastest-growing areas of US life sciences. Regulatory momentum, from the FDA real-world evidence framework under the 21st Century Cures Act, together with rising payer and HTA demand for real-world value, has moved RWE from a supporting role to a core capability, and investment in real-world data, analytics and AI has followed.

    Boston is the natural home for that conversation. The Massachusetts cluster is one of the densest life-sciences ecosystems in the world, from Harvard, MIT and Mass General Brigham to hundreds of biopharma headquarters and the Kendall Square innovation hub. It is where the people generating and buying real-world evidence already are.

    US Regulatory MomentumFDA real-world evidence framework under the 21st Century Cures Act.
    The Boston ClusterHarvard, MIT and Mass General Brigham on the doorstep.
    Where the Buyers AreHundreds of biopharma HQs and the Kendall Square hub.

    Choosing a partner

    How to Evaluate a Real-World Evidence Vendor

    Whatever category a company sits in, buyers weigh them against a consistent set of criteria. Use these to shortlist the right partner, then meet your shortlist face to face at RWE Connect 2026.

    Data Access & Governance
    The right data, responsibly sourced, consented and governed.
    Methodological Rigor
    Transparent, validated and reproducible methods.
    Therapeutic & Domain Expertise
    Depth in your disease area and its evidence needs.
    Regulatory & HTA Track Record
    A history of evidence that regulators and payers accept.
    Scale, Recency & Linkage
    Enough patients, refreshed often, and linkable across sources.
    Delivery & Partnership
    Clear timelines, communication and a genuine working partnership.

    RWE Connect 2026

    Get Your Company in Front of the Room

    150+ real-world evidence buyers, around 60% at Director or VP level and above, over two days in Boston. Request the prospectus and the team replies within one business day.

    • Exhibition space and live demos
    • Speaking and panel opportunities
    • Pre-scheduled 1:1 meetings with the buyers you name
    • Your brand across event materials and the website
    Request the Sponsorship Prospectus
    Three fields. We reply within one business day.

      No public pricing. Enquiry-led, no obligation.

      Real-World Evidence Companies: Common Questions

      What are real-world evidence companies?

      They provide the data, analytics and services used to generate evidence from outside the clinical trial, including real-world data platforms, AI and analytics providers, CROs, HEOR and market access consultancies, digital health platforms, and regulatory technology vendors.

      Which RWE companies are at RWE Connect 2026?

      Confirmed sponsors include Truveta (Platinum), Magnolia (Gold), Forian (Silver) and Arcadia (Thought Leadership Partner), alongside 40+ speakers from leading pharma and biotech.

      What types of companies sponsor an RWE conference?

      Real-world data and analytics platforms, AI and ML providers, CROs, HEOR and market access consultancies, digital health companies, and regulatory technology vendors, all of whom sell into RWE, HEOR, market access and data science teams.

      Who will my company meet at RWE Connect 2026?

      A room of 150+ RWE, HEOR, market access and data science professionals, around 60% at Director or VP level and above, from pharma, biotech and the wider life-sciences ecosystem.

      What is included in a sponsorship or exhibition package?

      Exhibition space, speaking or panel opportunities (tier dependent), pre-scheduled 1:1 meetings, and brand visibility across event materials. Request the prospectus for the full options; pricing is shared on enquiry.

      How do the pre-scheduled 1:1 meetings work?

      Through the Partnering Lounge, sponsors name the buyers they want to meet and the team books those meetings in advance, so your two days are spent with the right people.

      How do I choose a real-world evidence vendor?

      Assess data access and governance, methodological rigor, therapeutic expertise, regulatory and HTA track record, data scale and recency, and delivery. Meeting your shortlist face to face at RWE Connect 2026 shortens the process.

      What types of real-world evidence companies are there?

      Data and analytics platforms, healthcare AI providers, digital health companies, CROs, HEOR and market-access consultancies, and regulatory and compliance technology.

      What is the difference between a real-world data vendor and an RWE solutions provider?

      A data vendor supplies the underlying real-world data; a solutions provider designs the study and generates the evidence from it. Many companies do both.

      When and where is RWE Connect 2026?

      14 to 15 October 2026 at the Hampton Inn by Hilton, Boston Seaport District, Boston, MA.

      How do you choose a real-world evidence company?

      Assess data fit, methodological rigor, therapeutic expertise, regulatory track record, technology and how they work as a partner, against your specific need.

      What is the difference between an RWE company and a CRO?

      A CRO runs clinical research and trials, while an RWE company focuses on evidence from real-world data, though many CROs now offer real-world evidence services too.

      Related

      Join the Movement. Shape the Future.

      Be part of a community that’s redefining how the world measures healthcare impact.

      Join us at RWE Connect 2026
      where data meets decisions.

      Get Your Complimentary Delegate PassGet Your Complimentary Delegate PassGet Your Complimentary Delegate PassGet Your Complimentary Delegate PassGet Your Complimentary Delegate PassGet Your Complimentary Delegate Pass